Boston Scientific buy UBS Group AG
Start price
24.07.25
/
50%
€90.40
Target price
24.07.26
€114.66
Performance (%)
-29.87%
Price
20.02.26
€63.40
Summary
This prediction is currently active. The prediction for Boston Scientific disappoints with a performance of -29.87%. This prediction currently runs until 24.07.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Boston Scientific | 0.635% | 0.635% |
| iShares Core DAX® | 1,43 % | 2,63 % |
| iShares Nasdaq 100 | 1,89 % | -0,46 % |
| iShares Nikkei 225® | -1,62 % | 11,10 % |
| iShares S&P 500 | 1,92 % | 1,16 % |
Comments by UBS_Group_AG for this prediction
In the thread Boston Scientific diskutieren
Boston Scientific Corporation (NYSE: BSX) had its price target raised by analysts at UBS Group AG from $130.00 to $135.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat
Stopped prediction by UBS_Group_AG for Boston Scientific
Boston Scientific
Start price
Target price
Perf. (%)
€102.00
07.02.25
07.02.25
€125.53
07.02.26
07.02.26
-38.24%
08.02.26
08.02.26
Boston Scientific
Start price
Target price
Perf. (%)
€68.50
25.04.24
25.04.24
€83.95
25.04.25
25.04.25
30.51%
26.04.25
26.04.25